The research priorities are clear: Phase I safety trials in healthy volunteers must be completed, followed by Phase II efficacy trials for specific conditions if safety is confirmed
The practical implication is simple
however, its popularity is surging, leading to an unfortunate rise in its availability on the black market and from non-reputable sources
Incretin-like hormones, such as glucagon-like peptide-1 (GLP-1), exert their effects by inducing glucose-dependent effects on insulin secretion, inhibiting glucagon release, slowing gastric emptying, and reducing food intake, ultimately leading to weight loss [5, 6]
Stellavato A, La Noce M, Corsuto L, et al
The test was performed at least a week after spontaneous alternation for mice that underwent both tests